Literature DB >> 21370269

An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.

Anthony L Vaccarino1, Karen Anderson, Beth Borowsky, Kevin Duff, Joseph Giuliano, Mark Guttman, Aileen K Ho, Michael Orth, Jane S Paulsen, Terrence Sills, Daniel P van Kammen, Kenneth R Evans.   

Abstract

Although the Unified Huntington's Disease Rating Scale (UHDRS) is widely used in the assessment of Huntington disease (HD), the ability of individual items to discriminate individual differences in motor or behavioral manifestations has not been extensively studied in HD gene expansion carriers without a motor-defined clinical diagnosis (ie, prodromal-HD or prHD). To elucidate the relationship between scores on individual motor and behavioral UHDRS items and total score for each subscale, a nonparametric item response analysis was performed on retrospective data from 2 multicenter longitudinal studies. Motor and behavioral assessments were supplied for 737 prHD individuals with data from 2114 visits (PREDICT-HD) and 686 HD individuals with data from 1482 visits (REGISTRY). Option characteristic curves were generated for UHDRS subscale items in relation to their subscale score. In prHD, overall severity of motor signs was low, and participants had scores of 2 or above on very few items. In HD, motor items that assessed ocular pursuit, saccade initiation, finger tapping, tandem walking, and to a lesser extent, saccade velocity, dysarthria, tongue protrusion, pronation/supination, Luria, bradykinesia, choreas, gait, and balance on the retropulsion test were found to discriminate individual differences across a broad range of motor severity. In prHD, depressed mood, anxiety, and irritable behavior demonstrated good discriminative properties. In HD, depressed mood demonstrated a good relationship with the overall behavioral score. These data suggest that at least some UHDRS items appear to have utility across a broad range of severity, although many items demonstrate problematic features.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Year:  2011        PMID: 21370269      PMCID: PMC3157755          DOI: 10.1002/mds.23574

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  Clinical markers of early disease in persons near onset of Huntington's disease.

Authors:  J S Paulsen; H Zhao; J C Stout; R R Brinkman; M Guttman; C A Ross; P Como; C Manning; M R Hayden; I Shoulson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity.

Authors:  Carissa Nehl; Jane S Paulsen
Journal:  J Nerv Ment Dis       Date:  2004-01       Impact factor: 2.254

3.  Critical periods of suicide risk in Huntington's disease.

Authors:  Jane S Paulsen; Karin Ferneyhough Hoth; Carissa Nehl; Laura Stierman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

4.  Socio-psychiatric consequences of Huntington's disease.

Authors:  K Dewhurst; J E Oliver; A L McKnight
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

5.  Behavioral changes in Huntington Disease.

Authors:  D Craufurd; J C Thompson; J S Snowden
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2001 Oct-Dec

6.  Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.

Authors:  E D Louis; K E Anderson; C Moskowitz; D Z Thorne; K Marder
Journal:  Arch Neurol       Date:  2000-09

7.  A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.

Authors:  S Siesling; A H Zwinderman; J P van Vugt; K Kieburtz; R A Roos
Journal:  Mov Disord       Date:  1997-03       Impact factor: 10.338

8.  Differential functioning of the Beck depression inventory in late-life patients: use of item response theory.

Authors:  Yookyung Kim; Paul A Pilkonis; Ellen Frank; Michael E Thase; Charles F Reynolds
Journal:  Psychol Aging       Date:  2002-09

9.  An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies.

Authors:  Kenneth R Evans; Terrence Sills; David J DeBrota; Steve Gelwicks; Nina Engelhardt; Darcy Santor
Journal:  J Psychiatr Res       Date:  2004 May-Jun       Impact factor: 4.791

10.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

View more
  21 in total

1.  Robust Bayesian hierarchical model using normal/independent distributions.

Authors:  Geng Chen; Sheng Luo
Journal:  Biom J       Date:  2015-12-29       Impact factor: 2.207

2.  Tracking motor impairments in the progression of Huntington's disease.

Authors:  Jeffery D Long; Jane S Paulsen; Karen Marder; Ying Zhang; Ji-In Kim; James A Mills
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

Review 3.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

4.  Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study.

Authors:  Carla Piano; Anna Losurdo; Giacomo Della Marca; Marcella Solito; Giovanna Calandra-Buonaura; Federica Provini; Anna Rita Bentivoglio; Pietro Cortelli
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

5.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

Review 6.  The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.

Authors:  Anthony L Vaccarino; Kenneth R Evans; Amir H Kalali; Sidney H Kennedy; Nina Engelhardt; Benicio N Frey; John H Greist; Kenneth A Kobak; Raymond W Lam; Glenda MacQueen; Roumen Milev; Franca M Placenza; Arun V Ravindran; David V Sheehan; Terrence Sills; Janet B W Williams
Journal:  Innov Clin Neurosci       Date:  2016-10-01

Review 7.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 8.  [The presymptomatic stage of neurodegenerative disorders].

Authors:  C Klein; J Hagenah; B Landwehrmeyer; T Münte; T Klockgether
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

9.  Bayesian hierarchical model for multiple repeated measures and survival data: an application to Parkinson's disease.

Authors:  Sheng Luo; Jue Wang
Journal:  Stat Med       Date:  2014-06-17       Impact factor: 2.373

10.  Clinical and genetic investigation of a Brazilian family with Huntington's disease.

Authors:  L A Agostinho; M Spitz; J S Pereira; C L A Paiva
Journal:  Funct Neurol       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.